Glaukos Corporation — Cash Flow (NYSE:GKOS) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -22.99 M24.71 M-33.08 M-57.76 M-61.32 M-14.79 M -14.79 M Cash from investing activities -205.06 M-58.23 M44.78 M14.1 M47.83 M-77.61 M -77.61 M Cash from financing activities 262.54 M39.26 M6.25 M15.04 M91.54 M11.89 M 11.89 M Free cash flow -29.92 M-23.08 M-63.35 M-78.01 M-67.62 M-22.45 M -22.45 M

Haberler

Glaukos SVP Thurman 267 bin dolarlık GKOS hissesi sattı

Glaukos CFO Thurman 160 bin dolarlık hisse sattı

Piper Sandler, Glaukos hissesi için hedef fiyatı korudu

Glaukos Launches Epioxa, Boosts Growth in Corneal Treatments

Why Is Glaukos (GKOS) Down 14.7% Since Last Earnings Report?

Stifel, ürün momentumu nedeniyle Glaukos hissesi değerlendirmesini yineliyor

Stifel reiterates Glaukos stock rating on product momentum

Glaukos Misses Q4 Earnings Estimates, Raises 2026 Revenue Outlook

Needham, Glaukos’un hisse fiyat hedefini iDose ve Epioxa büyümesi nedeniyle yükseltti

Needham raises Glaukos stock price target on iDose, Epioxa growth

These Analysts Boost Their Forecasts On Glaukos Following Q4 Results - Glaukos (NYSE:GKOS)

Glaukos Corporation (GKOS) Q4 2025 Earnings Call Transcript